Current Aspects of Radiopharmaceutical Chemistry by Peter BrustCurrent Aspects of Radiopharmaceutical Chemistry by Peter Brust

Current Aspects of Radiopharmaceutical Chemistry

Guest editorPeter Brust

Paperback | August 15, 2018

Pricing and Purchase Info


Earn 418 plum® points

Prices and offers may vary in store


In stock online

Ships free on orders over $25

Not available in stores


Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) are in vivo molecular imaging techniques which are widely used in nuclear medicine for the diagnosis and treatment follow-up of many major diseases. They use biomolecules as probes, which are labeled with radionuclides of short half-lives, synthesized prior to the imaging studies. These probes are called radiopharmaceuticals. Their design and development require a rather interdisciplinary process involving many different disciplines of natural and health sciences. In addition to their diagnostic and therapeutic purposes in the field of nuclear medicine, radiopharmaceuticals provide powerful tools for in vivo pharmacology during the process of pre-clinical drug development to identify new drug targets, investigate the pathophysiology of diseases, discover potential drug candidates, and evaluate the pharmacokinetics and pharmacodynamics of drugs in vivo. Furthermore, they allow molecular imaging studies in various small-animal models of disease, including genetically engineered animals. The current collection of articles provides unique examples covering all major aspects in the field.

Title:Current Aspects of Radiopharmaceutical ChemistryFormat:PaperbackProduct dimensions:216 pages, 9.61 × 6.69 × 0.59 inShipping dimensions:9.61 × 6.69 × 0.59 inPublished:August 15, 2018Publisher:MDPI AGLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:3038971626

ISBN - 13:9783038971627